Prediction Efficiency of MADIT-ICD Benefit Score for Outcome in Asian Patients with Implantable...

Area of Science:

• Cardiology
• Medical Devices
• Clinical Research

Background:

• Not all heart failure patients benefit equally from prophylactic implantable cardioverter-defibrillators (ICDs).
• Accurate risk stratification is crucial for optimizing ICD therapy in primary prevention.
• Asian populations may have unique responses to ICDs.

Purpose of the Study:

• To evaluate the utility of the MADIT-ICD benefit score for risk-stratifying Asian patients with left ventricular ejection fraction (LVEF) ≤35% for primary prevention.
• To assess the score's ability to predict benefits from ICD implantation.

Main Methods:

• A retrospective study of 136 Asian patients with LVEF ≤35% who received an ICD for primary prevention.
• Patients were categorized into highest, intermediate, and lowest benefit groups based on the MADIT-ICD benefit score.
• Endpoints included ventricular tachycardia/fibrillation (VT/VF) and non-arrhythmic death.

Main Results:

• Patients in the highest benefit group showed a significantly higher occurrence of VT/VF compared to other groups.
• In the highest benefit group, the predicted risk of VT/VF was substantially higher than non-arrhythmic mortality (41.5% vs 2.4%).
• The predictive difference between VT/VF and non-arrhythmic mortality was attenuated in the lowest benefit group.

Conclusions:

• The MADIT-ICD benefit score is a valuable tool for assessing the benefits of primary prevention ICDs in Asian patients with reduced LVEF.
• The score aids in identifying patients most likely to benefit from ICD implantation.
• Risk stratification using the MADIT-ICD benefit score can help personalize ICD therapy decisions.